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ibernating Myocardium
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hahbudin H. Rahimtoola, MB, FRCP,
ACP, MACC, DSC (HON),†
iovanni La Canna, MD,‡
oberto Ferrari, MD, PHD§
os Angeles, California; and Milan, Ferrara,
nd Gussago (Brescia), Italy
evascularization of hibernating myocardium (HM) (1–5)
mproves or normalizes left ventricular (LV) ejection frac-
ion (EF) and the patient’s New York Heart Association
unctional class (6). Allman et al. (7) have analyzed data
rom 24 studies involving 3,088 patients who had LVEF of
.32  0.08 and follow-up at 25  10 months. Patients
ho had revascularization when compared to “medical
herapy” showed that (7): 1) in those with HM,
See page 969
ortality was lower (3.2% vs. 16.0 %, p  0.0001), and 2)
he lower the LVEF, the greater was the reduction in
ortality. In addition, the composite of subsequent myo-
ardial infarction (MI), heart failure, and unstable angina
as also lower (6.0% vs. 12.2%, p  0.001) (8). These
enefits were not seen in patients without HM but who
onetheless had been revascularized (7,8).
In this issue of the Journal, Ambrosio et al. (9) have
resented the findings of a carefully performed study which
hows that in patients with either non–Q-wave MI or no
revious MI but with LV wall motion abnormality and
M, there is remodeling of the LV; that is, LV end-
iastolic volume (EDV) and end–systolic volume (ESV) are
ncreased and the LV is more spherical. Thus, they have
ocumented that the mere presence of LV systolic dysfunc-
ion with HM can lead to LV remodeling. They have also
*Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
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riffith Professor of Cardiology and Professor of Medicine at the Keck School of
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f Cardiology Foundation, the American College of Physicians, Indiana University,
he University of California at Los Angeles, the University of California at Irvine,
orthwestern University, Cornell University, Thomas Jefferson University, Creightona
niversity, Cedars-Sinai Medical Center, Harvard Medical School, the University of
isconsin, Pfizer, ATS, Edwards LifeSciences, and St. Jude Medical.ocumented that: 1) revascularization in those with HM
esults in reverse remodeling; that is, there is a reduction of
he increased LVEDV and LVESV, the LV is less spheri-
al, and LVEF increases (for all changes p  0.00l); 2) this
everse remodeling was not seen in patients who did not
ave HM but nonetheless had been revascularized; and 3)
he extent of the reverse remodeling was related to the
umber of viable segments identified by “low-dose” dobut-
mine echocardiography and the LV spericity index at
aseline (for both changes, p  0.001).
The study by Ambrosio et al. (9) was well done: 1) the
nclusion criteria were appropriate; 2) patients who had
cute coronary syndrome in the preceding three months
ere excluded; 3) left ventricular dysfunction was recon-
rmed three weeks later, just before revascularization; 4)
ff-line analysis of the echocardiograms was performed by
wo investigators without knowledge of clinical and angio-
raphic data, and disagreements in interpretation were
esolved by consensus; 5) reproducibility of the LV volume
easurements was very good, the mean SD difference for
VEDV was 0.57  12 ml (r  0.96); 6) the intra- and
nterobserver agreement of stress-echocardiographic read-
ngs in their laboratory had previously been documented to
e 90%; 7) the follow-up study was performed 7.6  3.3
onths after revascularization; and 8) hibernating myocar-
ium was diagnosed by the response of the LV to “low dose”
obutamine.
Similar reverse remodeling was also seen in an ongoing,
ong-term prospective study (G. La Canna, personal com-
unication, 2005). Patients with HM who before revascu-
arization had shown improvement of LVEF with low-dose
obutamine had, by the time of hospital discharge after
oronary artery bypass graft surgery, reductions in
VEDV (from 194  46 ml to 179  41 ml; p  0.007)
nd in LVESV (from 141  40 ml to 102  40 ml, p 
.0001), and increases of LVEF (from 0.29  0.10 to
.43  0.13, p  0.0001) (10). In retrospect, remodeling
nd reverse remodeling should have been obvious from
he beginning (Fig. 1) (1).
The early remodeling documented in the study by
mbrosio et al. (9) provides one aspect of the early phase
f HM and provides an opportunity to develop a probable
ourse of progression and regression of LV remodeling
Fig. 2). The early stage of HM, when patients only have
all motion abnormalities and remodeling either has not
ccurred or is only minimal (Figs. 2B and 2C) may reverse
o normal (Fig. 2A), and thus may also be the “golden time”
or revascularization of HM. With time, LV remodeling
rogressively increases and the amount of benefit of reverse
emodeling may decline (Figs. 2C to 2D). In the end stage
f the disorder (Fig. 2E), the benefit of revascularization
eeds to be studied. If the patients only have single-vessel
isease, revascularization for HM will also need to be
erformed even if LV remodeling has occurred (Figs. 1, 2C
nd 2D).
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March 7, 2006:978–80 Editorial CommentThe findings in these studies raise an important clinical
uestion and a dilemma. Do all of these patients need a
iagnostic test for HM? Ideally, yes; but the important
uestion is, which non-invasive test(s) should one use (10)?
review has shown the sensitivity, specificity, and predic-
ive accuracies of dobutamine echocardiography; radionu-
lide studies and positron emission tomography range from
0% to 93% (Table 1) (11). Positron emission tomography
s the most sensitive but the least specific. Dobutamine
chocardiography provided a good and almost balanced
ensitivity and specificity (Table 1). Recently, cardiovascular
igure 1. Preoperative and postoperative left ventricular function in a pati
nterior descending coronary artery; LVEDV  left ventricular end-diastol
nd-systolic volume; LVSV  left ventricular stroke volume.igure 2. Diagrammatic representation of postulated progressive changes in a
oderate remodeling (C and D), and end stage (E) of the disorder. For detailagnetic resonance (CMR) has brought a lot of excitement
o the field (12) because of its sensitivity in detecting and its
bility to better determine the extent of infarcted myocar-
ium. A recent review (13) has clarified the strengths and
eaknesses of CMR in the diagnosis of myocardial viability;
t has also emphasized additional studies of CMR that need
o be performed. Two studies using only high-quality,
wo-dimensional echocardiograms showed that when the
V wall thickness of the affected region of LV systolic
ysfunction was 5 to 6 mm, the probability of recovery of
unction was 5% (14,15). Baer et al. (16) have docu-
ith hibernating myocardium. Adapted from Rahimtoola (1). LAD  left
ume; LVEF  left ventricular ejection fraction; LVESV  left ventricularent wpatient with hibernating myocardium and no remodeling (B), mild to
s, see text. WMA  wall motion abnormality.
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Editorial Comment March 7, 2006:978–80ented that patients with LV wall thickness on CMR of
5.5 mm had preserved glucose utilization, whereas those
ith wall thickness 5.5 mm had reduced glucose utiliza-
ion. With wall thickness 5 to 6 mm, recovery of function
as about 50%, and an additive test, dobutamine echocar-
iogram or radionuclide study, provided equal incremental
iagnostic values of about 25% to 30% in predicting
mprovement of LVEF after revascularization (14,15). Left
entricular wall thickness by echocardiography appears to be
he simplest non-invasive test. The role of contrast echo-
ardiography and of Doppler tissue imaging to assess wall
hickness and wall motion needs to be explored. Patients
ho before revascularization showed improvement of wall
otion abnormalities with low-dose dobutamine exhibited
greater amount of reverse remodeling after revasculariza-
ion (9,14,15); thus, low-dose dobutamine echocardiogra-
hy is clinically useful and can be of incremental clinical
alue when combined with any of the other test(s), if it is
roperly done.
The dilemma is the lack of perfect, or a 95% accurate, test
f HM. Therefore, there continues to be a need for further
esearch and appropriate clinical judgment (17). One such
xample for the latter can be: In selected patients, if the
est(s) for HM are equivocal and revascularization is the
est, or possibly the only good, chance of improvement of
V function, revascularization should be seriously consid-
red if it can be performed at low risk with a high
robability of success.
eprint requests and correspondence: Dr. Shahbudin H.
ahimtoola, University of Southern California, 2025 Zonal
able 1. Sensitivity, Specificity, and Predictive Accuracies for
mprovement of Left Ventricular Function After Revascularization
Sensitivity
(%)
Specificity
(%)
Predictive Values of
Positive
Test (%)
Negative
Test (%)
obutamine
echocardiography*
81 80 77 85
adionuclide† 81–86 50–66 69–71 77–80
ositron-emission
tomography‡
93 58 71 86
32 studies, 1,090 patients; †53 studies; 1,346 patients; ‡20 studies; 598 patients.
dapted from Bax J et al. (11).venue, GNH #7131, Los Angeles, California 90033.EFERENCES
1. Rahimtoola SH. Coronary bypass surgery for chronic angina—1981.
A perspective. Circulation 1982;65:225–41.
2. Rahimtoola SH. A perspective on the three large multi-center ran-
domized clinical trials of coronary bypass surgery for chronic stable
angina. Circulation 1985;72 Suppl V:123–35.
3. Braunwald E, Rutherford J. Reversible ischemic left ventricular dys-
function: Evidence of the “hibernating myocardium”. J Am Coll
Cardiol 1986;8:1467–70.
4. Rahimtoola SH. The hibernating myocardium. Am Heart J 1989;117:
211–3.
5. Heusch G, Schulz R, Rahimtoola SH. Myocardial hibernation: a
delicate balance. Am J Physiol Heart Circ Physiol 2005;288:H984–99.
6. Ferrari R. Hibernating myocardium: an adaptive phenomenon? In:
Yellon DM, Rahimtoola SH, Opie LH, editors. New Ischemic
Syndromes. New York, NY: Authors Publishing House, Tallman,
New York Lippincott-Raven Publishers, 1997:204–14.
7. Allman KC, Shaw LJ, Hachamovitch R, Udelson E. Myocardial
viability testing and impact of revascularization on prognosis in
patients with coronary artery disease and left ventricular dysfunction: a
meta-analysis. J Am Coll Cardiol 2003;39:1151–8.
8. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Prognostic value
of myocardial viability testing: a meta-analysis. Circulation 2000;102
Suppl II:576.
9. Carluccio E, Biagioli P, Alunni G, et al. Patients with hibernating
myocardium show altered left ventricular volumes and shape, which
revert after revascularization: evidence that dyssynergy might directly
induce cardiac remodeling. J Am Coll Cardiol 2006;47:969–77.
0. Bonow RO. Identification of viable myocardium. Circulation 1996;
94:2674–80.
1. Bax JJ, Poldermans D, Elhendy A, Boersma E, Rahimtoola SH.
Sensitivity, specificity, and predictive accuracies of various non-
invasive techniques for detecting hibernating myocardium. Curr Probl
Cardiol 2001;26:141–88.
2. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced
magnetic resonance imaging to identify reversible myocardial dysfunc-
tion. N Engl J Med 2000;343:1445–53.
3. Ducci CB, Wu E, Lee DC, Holly TA, Klocke FJ, Bonow RO.
Contrast-enhanced cardiac magnetic resonance in the evaluation of
myocardial infarction and myocardial visibility in patients with isch-
emic heart disease. Curr Probl Cardiol 2006;31:121–68.
4. Cwajg J, Cwajg E, Nagueh SF, et al. End-diastolic wall thickness as
predictor of recovery of function in myocardial hibernation. Relation to
rest-redistribution Tl-201 tomography and dobutamine stress echo-
cardiography. J Am Coll Cardiol 2000;35:1152–61.
5. La Canna G, Rahimtoola SH, Visioli O, et al. Sensitivity, specificity,
and predictive accuracies of non-invasive tests, singly and in combi-
nation, for diagnosis of hibernating myocardium. Eur Heart J 2000;
21:1358–67.
6. Baer FM, Voth E, Schneider CA, Thiessen P, Schicha H, Sechtem U.
Comparison of low-dose dobutamine-gradient-echo magnetic reso-
nance imaging and positron emission tomography with [18F] fluoro-
deoxyglucose in patients with coronary artery disease. A functional and
morphological approach to the detection of residual myocardial via-
bility. Circulation 1995;91:100–15.
7. Rahimtoola SH. Importance of diagnosing hibernating myocardium:
how and in whom? J Am Coll Cardiol 1997;30:1701–6.
